Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01839916 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
77
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Chicago

Collaborators